In a filing, Altimmune Inc revealed its Director Pisano Wayne acquired Company’s shares for reported $20410.0 on Jan 08 ’26. In the deal valued at $4.08 per share,5,000 shares were bought. As a result of this transaction, Pisano Wayne now holds 13,498 shares worth roughly $54261.95999999999.
Then, Jorkasky Diane bought 527 shares, generating $2,003 in total proceeds. Upon buying the shares at $3.80, the Director now owns 527 shares.
Before that, GILL JOHN bought 12,500 shares. Altimmune Inc shares valued at $51,250 were divested by the Director at a price of $4.10 per share. As a result of the transaction, GILL JOHN now holds 12,500 shares, worth roughly $50249.99999999999.
A number of analysts have revised their coverage, including William Blair’s analysts, who began to cover the stock in late February with a ‘”a Mkt perform”‘ rating. Stifel began covering ALT with “Buy” recommendation on January 08, 2025. UBS started covering the stock on November 12, 2024. It rated ALT as “a Buy”.
Price Performance Review of ALT
On Monday, Altimmune Inc [NASDAQ:ALT] saw its stock fall -1.47% to $4.02. Over the last five days, the stock has gained 14.53%. Altimmune Inc shares have fallen nearly -45.01% since the year began. Nevertheless, the stocks have risen 11.36% over the past one year.
How much short interest is there in Altimmune Inc?
A steep rise in short interest was recorded in Altimmune Inc stocks on 2025-12-15, growing by 0.43 million shares to a total of 23.72 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 23.29 million shares. There was a rise of 1.83%, which implies that there is a positive sentiment for the stock.
